About Heer Pharma
Heer Pharma is a Healthcare company based in Mumbai (India) founded in 1993. It manufactures and exports APIs, veterinary drugs, and excipients for global markets. It operates on a B2B model. Its Indian entity Heer Pharma Private Limited reported revenue of ₹52.00 Cr. Heer Pharma offers products and services including APIs, Veterinary Drugs, Excipients, Nimesulide, and Glibenclamide. Its focus areas include Pharmaceuticals, APIs, Human Drugs and Veterinary Drugs. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Heer Pharma Private Limited, established in 1993 and headquartered in Mumbai, India, is a pharmaceutical company that produces and exports APIs, veterinary drugs, and excipients. It operates through manufacturing facilities in Ankleshwar, Gujarat, and maintains a warehouse in Bhiwandi, Maharashtra. The company serves international markets in countries like Switzerland, Brazil, Jordan, and Turkey via business alliances and exports, focusing on ethical veterinary and human pharmaceuticals to meet global demands.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website heerpharma.com
- Legal Name Heer Pharma Private Limited
- Date of Incorporation 22 Jun, 1993
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹52.00 Cr
FY 2024 · -4% YoY
- Net Profit₹1.17 Cr
FY 2024 · 2% margin
- EBITDA₹1.63 Cr
FY 2024 · 3% margin
Associated legal entities of Heer Pharma
Heer Pharma operates through Heer Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Heer Pharma Private Limited CIN U51900MH1993PTC072516 | Active | 22 Jun 1993 | Mumbai, Maharashtra | ₹52.0 Cr | – | 3 | View details |
Products & Services of Heer Pharma
Heer Pharma offers a comprehensive portfolio of products and services, including APIs, Veterinary Drugs, Excipients, Nimesulide, and Glibenclamide.
Raw materials used in drug manufacturing for various applications
Medications for treating animal diseases and conditions
Inactive substances that aid in drug formulation processes
Anti-inflammatory drug for pain and fever relief
Medication for managing diabetes symptoms
Board of directors of Heer Pharma Private Limited (Heer Pharma)
Heer Pharma Private Limited is the primary company behind Heer Pharma. The board of Heer Pharma Private Limited currently have 3 directors; the longest-serving is Mrudula Kirit Shah, appointed in 1993.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mrudula Kirit Shah DIN 01500944 | Director | 22 Jun 1993 | 33 yrs 3 mo | Heer Pharma Private Limited |
| Prashant Kirit Shah DIN 01500915 | Managing Director | 04 Apr 1995 | 31 yrs 6 mo | Heer Pharma Private Limited |
| Beejal Prashant Shah DIN 01500972 | Whole-time director | 03 Apr 2006 | 20 yrs 6 mo | Heer Pharma Private Limited |
Financials of Heer Pharma
Figures of Heer Pharma Private Limited, the primary company behind Heer Pharma, for FY 2024. Revenue was ₹52.00 Cr (-4% year on year). Net profit was ₹1.17 Cr (2% margin). EBITDA was ₹1.63 Cr (3% margin). Revenue has grown at a compounded annual rate of -2% over three years and +16% over five years.
- ₹52.00 CrRevenue · FY 2024 · -4% YoY
- ₹1.17 CrNet profit · 2% margin
- ₹1.63 CrEBITDA · 3% margin
- ₹1.1 LakhPaid-up capital
- -2%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Heer Pharma Private Limited are on its company page.
Detailed financial statements for Heer Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Heer Pharma
Heer Pharma has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Heer Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Heer Pharma
The website of Heer Pharma (heerpharma.com) receives about 1K visits a month.
- Monthly visits1K
▲ 34.6% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Heer Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Heer Pharma
Heer Pharma was founded in 1993.
Heer Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Heer Pharma, Heer Pharma Private Limited, reported revenue of ₹52.00 Cr for FY 2024, down 4% year on year.
Heer Pharma Private Limited, established in 1993 and headquartered in Mumbai, India, is a pharmaceutical company that produces and exports APIs, veterinary drugs, and excipients. It operates through manufacturing facilities in Ankleshwar, Gujarat, and maintains a warehouse in Bhiwandi, Maharashtra. The company serves international markets in countries like Switzerland, Brazil, Jordan, and Turkey via business alliances and exports, focusing on ethical veterinary and human pharmaceuticals to meet global demands.
Heer Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Heer Pharma offers APIs, Veterinary Drugs, Excipients, Nimesulide, and Glibenclamide.
Heer Pharma operates through Heer Pharma Private Limited.
The legal entities of Heer Pharma currently have 3 directors, including Mrudula Kirit Shah, Prashant Kirit Shah, Beejal Prashant Shah.